BridgeBio Pharma, Inc. (BBIO)
76.75
-0.76
(-0.98%)
USD |
NASDAQ |
Apr 17, 16:00
77.28
+0.53
(+0.69%)
Pre-Market: 08:30
BridgeBio Pharma SG&A Expense (Quarterly) : 158.08M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Pfizer Inc. | 4.162B |
| Mirum Pharmaceuticals, Inc. | 74.13M |
| Insmed, Inc. | 212.48M |
| Eli Lilly & Co. | 3.132B |
| Vanda Pharmaceuticals, Inc. | 62.98M |